Holen Sie sich die Stockscreener-App
8.96
2.05%
0.18
Schlusskurs vom Vortag:
$8.78
Offen:
$8.91
24-Stunden-Volumen:
1.01M
Relative Volume:
3.67
Marktkapitalisierung:
$353.81M
Einnahmen:
$68.68M
Nettoeinkommen (Verlust:
$-60.84M
KGV:
-5.60
EPS:
-1.6
Netto-Cashflow:
$-38.42M
1W Leistung:
+28.55%
1M Leistung:
+44.75%
6M Leistung:
+23.93%
1J Leistung:
-38.21%
1-Tages-Spanne:
$8.63
$9.35
1-Wochen-Bereich:
$6.495
$9.37
52-Wochen-Spanne:
$5.46
$14.20
Pulmonx Corp Stock (LUNG) Company Profile
Firmenname
Pulmonx Corp
Sektor
Branche
Telefon
650-364-0400
Adresse
700 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie LUNG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
8.96 | 353.81M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-04 | Eingeleitet | Lake Street | Buy |
| 2024-02-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Neutral |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-10-26 | Eingeleitet | BofA Securities | Buy |
| 2020-10-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Eingeleitet | Stifel | Buy |
| 2020-10-26 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Pulmonx Corp Aktie (LUNG) Neueste Nachrichten
Stock summary: Pulmonx witnessed weekly surge of 20.43% after fourth-quarter earnings exceed expectations - Business Upturn
Top 3 Health Care Stocks You May Want To Dump In February - Benzinga
Pulmonx Corporation (NASDAQ:LUNG) Q4 2024 Earnings Call Transcript - Insider Monkey
Citi raises Pulmonx stock target following record revenue By Investing.com - Investing.com Nigeria
Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... - Yahoo Finance
Pulmonx earnings beat by $0.12, revenue topped estimates - Investing.com
Pulmonx Corporation shares spike on record-breaking Q4 revenue - Mugglehead
Earnings call transcript: Pulmonx Q4 2024 earnings beat expectations, stock jumps - Investing.com
Can Pulmonx's 22% Revenue Surge and Treatment Center Expansion Transform Severe COPD Care? - StockTitan
What To Expect From Pulmonx Corp (LUNG) Q4 2024 Earnings - Yahoo Finance
Exclusive: Pulmonx Reveals Future Roadmap at Major Healthcare Investor Summit - StockTitan
Pulmonx Co. (NASDAQ:LUNG) Stake Lifted by SG Americas Securities LLC - Defense World
Pulmonx (LUNG) Projected to Post Quarterly Earnings on Wednesday - Defense World
Pulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Pulmonx Earnings Watch: Key Q4 Financial Results Coming February 19Mark Your Calendar - StockTitan
Morgan Stanley Reduces Stake in Pulmonx Corp by 21.74% - GuruFocus.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket - Benzinga
Pulmonx Corp to Host Earnings Call - ACCESS Newswire
Pulmonx Co. (NASDAQ:LUNG) Director Sells $15,188.78 in Stock - MarketBeat
Pulmonx director French Glendon E. III sells shares worth $29,625 - MSN
Pulmonx director French Glendon E. III sells shares worth $29,625 By Investing.com - Investing.com Canada
Pulmonx Co. (NASDAQ:LUNG) Shares Bought by Barclays PLC - Defense World
JPMorgan Chase & Co. Buys 25,002 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Brokerages Set Pulmonx Co. (NASDAQ:LUNG) Price Target at $12.75 - MarketBeat
Geode Capital Management LLC Increases Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Barclays PLC Boosts Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World
State Street Corp Buys 18,592 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives $12.75 Average Price Target from Analysts - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Citi downgrades Pulmonx stock to Neutral stock, citing lack of clear catalysts for growth - Investing.com
Pulmonx's (LUNG) "Neutral" Rating Reaffirmed at Citigroup - MarketBeat
Jacobs Levy Equity Management Inc. Sells 188,926 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Shares Purchased by Fmr LLC - Defense World
Fmr LLC Increases Holdings in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Polar Asset Management Partners Inc. Takes Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Atom Investors LP Trims Stock Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx corp general counsel sells shares worth $34,004 By Investing.com - Investing.com Nigeria
Pulmonx chief commercial officer sells shares worth $27,063 By Investing.com - Investing.com Canada
Pulmonx corp general counsel sells shares worth $34,004 - Investing.com
Pulmonx chief commercial officer sells shares worth $27,063 - Investing.com
Parkman Healthcare Partners LLC Acquires Shares of 206,444 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx director French sells $132,600 in stock By Investing.com - Investing.com Nigeria
Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World
Pulmonx director French sells $132,600 in stock - Investing.com
Millrace Asset Group Inc. Purchases Shares of 167,725 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? - Yahoo Finance
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance
Finanzdaten der Pulmonx Corp-Aktie (LUNG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pulmonx Corp-Aktie (LUNG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| French Glendon E. III | Director |
Jan 16 '25 |
Sale |
6.53 |
2,326 |
15,189 |
1,069,648 |
| French Glendon E. III | Director |
Jan 17 '25 |
Sale |
6.50 |
2,221 |
14,436 |
1,067,427 |
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):